Get the Stockscreener App
0.4552
6.76%
-0.033
After Hours:
.46
0.0048
+1.05%
Helius Medical Technologies Inc stock is traded at $0.4552, with a volume of 168.68K.
It is down -6.76% in the last 24 hours and down -7.57% over the past month.
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
See More
Previous Close:
$0.4882
Open:
$0.455
24h Volume:
168.68K
Relative Volume:
0.40
Market Cap:
$1.70M
Revenue:
$792.00K
Net Income/Loss:
$-12.69M
P/E Ratio:
-0.0207
EPS:
-22
Net Cash Flow:
$-10.55M
1W Performance:
+0.66%
1M Performance:
-7.57%
6M Performance:
-63.29%
1Y Performance:
-92.84%
1-Day Range:
$0.4532
$0.5008
1-Week Range:
$0.4151
$0.52
52-Week Range:
$0.373
$9.50
Helius Medical Technologies Inc Stock (HSDT) Company Profile
Name
Helius Medical Technologies Inc
Sector
Industry
Phone
215-944-6100
Address
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
Compare HSDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
0.4552 | 1.70M | 792.00K | -12.69M | -10.55M | -22.00 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-21 | Initiated | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc Stock (HSDT) Latest News
Newtown-based Helius Medical Technologies Explores ‘Strategic Alternatives’ to Boost Stockholder Value - BUCKSCO.Today
Helius Medical Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Helius Medical Technologies Reports Q3 2024 Earnings - TipRanks
Helius Medical Technologies Considers Strategic Alternatives Amid Financial Challenges - MSN
Helius Medical Technologies Seeks Fair Market Access for PoNS Device Amid CMS Pricing Challenges - MSN
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN
Modular Medical announces proposed public offering - MSN
Helius to explore 'strategic alternatives' with revenue from flagship product stunted by pricing issues - The Business Journals
Helius Medical Explores Strategic Alternatives - Marketscreener.com
Regenxbio down 13% ahead of data readout for muscular dystrophy asset - MSN
Grandshores Technology Expects Increased Loss Amid Forex Challenges - MSN
Helius Medical Technologies Initiates Strategic Alternatives to Maximize Stockholder ValueNEWTOWN, Pa., Nov. 18, 2024 / Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced on November 18, 2024, the initiation of a process to explore strategic - Defense World
Helius seeks fair market access for MS treatment device By Investing.com - Investing.com Australia
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives - GlobeNewswire
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for Its Portable Neuromodulation Stimulator Device - Marketscreener.com
Helius Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-Compliance - TipRanks
Helix Biopharma announces CFO resignation - MSN
Helius Medical Technologies Challenges CMS Over PoNS Payment Rates - MSN
Helius Medical Technologies to Shine at ThinkEquity Conference in NYC! - MSN
Alignment Healthcare to Announce Third Quarter 2024 Financial Results and Host Conference Call Tuesday, Oct. 29, 2024 - The Manila Times
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference - GlobeNewswire
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference - GlobeNewswire Inc.
Adversity is less terrifying than hope: Helius Medical Technologies Inc (HSDT) - SETE News
Maxim cuts Helius Medical shares to hold on CMS reimbursement woes - Investing.com India
HSDT’s Market Whiplash: -95.35% YTD Decline, -53.82% Plunge in 30 Days - The InvestChronicle
Maxim cuts Helius Medical shares to hold on CMS reimbursement woes By Investing.com - Investing.com South Africa
Financial Health Check: Examining Helius Medical Technologies Inc (HSDT)’s Key Ratios - The Dwinnex
Helius to challenge CMS’ reimbursement determination for PoNS - Medical Buyer
Helius challenges CMS over PoNS device reimbursement rate - Investing.com India
Helius challenges CMS over PoNS device reimbursement rate By Investing.com - Investing.com South Africa
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece - The Manila Times
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from - The Bakersfield Californian
Helius Medical Technologies, Inc. Announces Reimbursement - GlobeNewswire
Helius Medical stock hits 52-week low at $0.5 amid sharp decline By Investing.com - Investing.com South Africa
Helius Medical stock hits 52-week low at $0.5 amid sharp decline - Investing.com
Helius Medical Technologies Reports Positive Preliminary Results from PoNSTEP Study - MSN
Financial Health Report: Helius Medical Technologies Inc (HSDT)’s Ratios Tell a Tale - The Dwinnex
HSDT stock touches 52-week low at $0.55 amid sharp annual decline By Investing.com - Investing.com South Africa
HSDT stock touches 52-week low at $0.55 amid sharp annual decline - Investing.com India
HSDT’s price-to-sales ratio: A comparative analysis with its peers - US Post News
Helius reports positive preliminary PoNS study results for MS - Investing.com
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study - GlobeNewswire
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Sees Large Growth in Short Interest - Defense World
Is The Market Rewarding Helios Technologies, Inc. (NYSE:HLIO) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - Yahoo Finance
Taking a Closer Look At Harmonic, Inc. (HLIT) Following Its Recent Trade - Knox Daily
Helios Technologies Extends History of Quarterly Dividends With 111th Consecutive Cash Dividend - Business Wire
Halfords Group (OTCMKTS:HLFDY) Stock Price Down 3.1% - Defense World
Health Check: Experts deliver their verdict on the Healius imaging deal and it’s ‘yeah nah’ - Stockhead
Helius Medical Technologies Inc Stock (HSDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):